Biosimilar drugs could save up to €98bn by 2020, says IMS
But savings from lower-cost copies depend on doctor education, healthcare provider strategies
AbbVie raises bid for drugmaker rival Shire to £51.15 a share
Shire said previous £46.26 cash-and-stock proposal undervalued the pharma company
US drugmaker AbbVie says Shire rejected bid approach
Irish-domiciled Shire viewed as prime takeover target for US pharmaceutical giants
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Election 2024
Full general election coverage including analysis and results for all 43 constituencies
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices